https://www.selleckchem.com/products/GDC-0941.html
With direct-acting antivirals dramatically reshaping the public health response to the hepatitis C virus(HCV), prisons are set to play a critical role in elimination efforts. Despite the theoretical demonstration of HCV treatment-as-prevention in prison in mathematical modeling, limited empirical data exist. The Australian 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C) is the world's first trial of HCV treatment-as-prevention in prison. Drawing on interviews with HCV expert stakeholders, this paper explores
إعجاب
علق
شارك
